S&P 500   2,617.34 (+5.17%)
DOW   22,134.43 (+5.14%)
QQQ   192.64 (+5.06%)
AAPL   253.81 (+5.14%)
FB   161.79 (+4.94%)
MSFT   161.46 (+4.96%)
GOOGL   1,150.54 (+5.29%)
AMZN   1,964.05 (+3.01%)
CGC   14.03 (+5.89%)
NVDA   260.75 (+6.86%)
BABA   194.90 (+4.16%)
MU   44.55 (+8.08%)
GE   7.13 (+5.79%)
TSLA   509.47 (+6.14%)
AMD   45.86 (+7.68%)
T   28.86 (+5.10%)
F   4.53 (+7.09%)
NFLX   371.45 (+2.68%)
BAC   21.14 (+5.54%)
GILD   76.49 (-2.20%)
DIS   97.14 (+3.47%)
S&P 500   2,617.34 (+5.17%)
DOW   22,134.43 (+5.14%)
QQQ   192.64 (+5.06%)
AAPL   253.81 (+5.14%)
FB   161.79 (+4.94%)
MSFT   161.46 (+4.96%)
GOOGL   1,150.54 (+5.29%)
AMZN   1,964.05 (+3.01%)
CGC   14.03 (+5.89%)
NVDA   260.75 (+6.86%)
BABA   194.90 (+4.16%)
MU   44.55 (+8.08%)
GE   7.13 (+5.79%)
TSLA   509.47 (+6.14%)
AMD   45.86 (+7.68%)
T   28.86 (+5.10%)
F   4.53 (+7.09%)
NFLX   371.45 (+2.68%)
BAC   21.14 (+5.54%)
GILD   76.49 (-2.20%)
DIS   97.14 (+3.47%)
S&P 500   2,617.34 (+5.17%)
DOW   22,134.43 (+5.14%)
QQQ   192.64 (+5.06%)
AAPL   253.81 (+5.14%)
FB   161.79 (+4.94%)
MSFT   161.46 (+4.96%)
GOOGL   1,150.54 (+5.29%)
AMZN   1,964.05 (+3.01%)
CGC   14.03 (+5.89%)
NVDA   260.75 (+6.86%)
BABA   194.90 (+4.16%)
MU   44.55 (+8.08%)
GE   7.13 (+5.79%)
TSLA   509.47 (+6.14%)
AMD   45.86 (+7.68%)
T   28.86 (+5.10%)
F   4.53 (+7.09%)
NFLX   371.45 (+2.68%)
BAC   21.14 (+5.54%)
GILD   76.49 (-2.20%)
DIS   97.14 (+3.47%)
S&P 500   2,617.34 (+5.17%)
DOW   22,134.43 (+5.14%)
QQQ   192.64 (+5.06%)
AAPL   253.81 (+5.14%)
FB   161.79 (+4.94%)
MSFT   161.46 (+4.96%)
GOOGL   1,150.54 (+5.29%)
AMZN   1,964.05 (+3.01%)
CGC   14.03 (+5.89%)
NVDA   260.75 (+6.86%)
BABA   194.90 (+4.16%)
MU   44.55 (+8.08%)
GE   7.13 (+5.79%)
TSLA   509.47 (+6.14%)
AMD   45.86 (+7.68%)
T   28.86 (+5.10%)
F   4.53 (+7.09%)
NFLX   371.45 (+2.68%)
BAC   21.14 (+5.54%)
GILD   76.49 (-2.20%)
DIS   97.14 (+3.47%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Arbutus BiopharmaAthersysArcturus TherapeuticsTheratechnologiesAvenue Therapeutics
SymbolNASDAQ:ABUSNASDAQ:ATHXNASDAQ:ARCTOTCMKTS:THERFNASDAQ:ATXI
Price Information
Current Price$0.96$2.77$13.33N/A$8.98
52 Week RangeBuyBuyBuyHoldBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldBuy
Consensus Price Target$6.25$9.50$23.17$6.00$12.00
% Upside from Price Target551.04% upside242.96% upside73.79% upside∞ upside33.63% upside
Trade Information
Market Cap$62.74 million$472.74 million$196.64 million$117.73 million$146.95 million
Beta2.77-1.711.70.580.08
Average Volume1,088,7036,468,088241,41025,67770,287
Sales & Book Value
Annual Revenue$6.01 million$5.63 million$20.79 million$45.18 millionN/A
Price / Sales11.0180.769.710.00N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/A177.07N/A
Book Value($1.04) per share$0.15 per share$1.27 per share$0.47 per share$0.41 per share
Price / Book-0.9218.4710.500.00N/A
Profitability
Net Income$-153,720,000.00$-44,580,000.00$-25,990,000.00$-4,660,000.00$-25,910,000.00
EPS($1.62)N/A($2.15)N/A($1.65)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-2,517.15%N/A-125.02%-11.57%N/A
Return on Equity (ROE)-298.87%-148.22%-409.05%-14.31%-195.47%
Return on Assets (ROA)-52.04%-88.61%-58.51%-4.25%-151.88%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A1.70%N/A
Current Ratio11.99%2.90%N/A2.69%4.22%
Quick Ratio11.99%2.90%N/A2.19%4.22%
Ownership Information
Institutional Ownership Percentage35.19%21.17%30.10%1.37%9.43%
Insider Ownership Percentage9.60%15.31%18.10%N/A5.00%
Miscellaneous
Employees797572326
Shares Outstanding68.94 million164.15 million15.14 million76.95 million16.68 million
Next Earnings Date5/4/2020 (Estimated)5/13/2020 (Estimated)5/11/2020 (Estimated)N/A5/11/2020 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel